CNE1000013Q9
CNE1000013Q9
SHANGHAI GANGLIAN
Loading chart...
Elevated Business & Solvency Risk
Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 50/100).
Volatility Risk
Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.
Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta
Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.7x).
Beta (Market Relation)
0.67x
DefensiveVolatility (5Y p.a.)
52.5% p.a.
5-Year HorizonMax Drawdown (5Y)
-66.4%
5-Year HorizonSharpe Ratio
-0.20
Return / RiskSpeculative / High Risk: Score Basis:
Multi-Horizon Risk & Performance Matrix
Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.
High Volatility
Timeframe | Volatility (p.a.) | Max Drawdown | Sharpe Ratio | Return (p.a.) |
|---|---|---|---|---|
| 1 Year | — | — | — | -18.6% |
| 3 Years | 51.6% | -50.8% | -0.24 | -10% |
| 5 Years | 52.5% | -66.4% | -0.2 | -7.9% |
| 10 Years | 48.6% | -73.9% | -0.1 | -2.3% |
Automated Risk & Health Notes (Red Flags)
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Critical leverage: Debt-to-Equity is at 427%.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (52.5% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -73.9% in the extended horizon.